Allan Kermode

30PUBLICATIONS
144CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNeurology and neuromuscular diseasesBiomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 03, 2026
Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study.

|Jul 21, 2026
Causal effects of multiple sclerosis therapies in left-truncated registry data.

|May 20, 2026
Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

|Apr 01, 2026
Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Andrea Surcinelli, Tomas Kalincik, Izanne Roos

|Mar 05, 2026
Impact of Age at Onset on Relapse and Disability in AQP4-IgG Neuromyelitis Optica Spectrum Disorder.

Pakeeran Siriratnam, Vilija G Jokubaitis, Anneke Van Der Walt

Pageof 5

Frequent Collaborators

12 joint publications

Tomas Kalincik

11 joint publications

Anneke van der Walt

7 joint publications

Vilija Jokubaitis

7 joint publications

Helmut Butzkueven